Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abiomed Inc (NQ: ABMD ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Abiomed Inc < Previous 1 2 3 Next > Risk Vs Reward Vs Folly: Navigating Investment Choices September 29, 2023 During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of... Via Talk Markets Is It Too Late to Buy Johnson & Johnson's Stock? April 28, 2023 This healthcare juggernaut's recent quarterly results prove just how strong its business is. Via The Motley Fool 2 Best Buffett Stocks to Buy for the Long Haul December 27, 2022 Both of these stocks look like bargains right now. Via The Motley Fool Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks December 21, 2022 Even if interest rates go up, you likely won't need to worry about these stocks. Via The Motley Fool The Best Stocks to Invest $20,000 in Right Now December 21, 2022 The investments you make now could power your portfolio returns for years to come. Via The Motley Fool Warren Buffett Loves These Stocks. Should You Buy Them Before 2023? December 16, 2022 There's a lot more ahead for these market giants. Via The Motley Fool If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today December 08, 2022 Via Benzinga Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years November 21, 2022 Via Benzinga Will Investors Notice Exciting Sign On Abiomed's Chart? November 16, 2022 Via Benzinga Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look? December 14, 2022 The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI... Via Benzinga 2 Top Dividend Kings to Buy for the Long Haul December 14, 2022 No matter how much changes, these two healthcare giants keep performing. Via The Motley Fool This Monster Dividend Stock Isn't Done Growing December 08, 2022 Is another deal on the way for Johnson & Johnson? Via The Motley Fool Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi December 05, 2022 There are now two companies in the ring for a Horizon takeover. Via Investor's Business Daily 3 Healthcare Stocks to Buy and Hold for the Next 10 Years December 02, 2022 This space is ripe with opportunities for investors. Via The Motley Fool Beat the Dow Jones With This Unstoppable Dividend Stock November 05, 2022 Johnson & Johnson has outperformed the Dow so far this year. Via The Motley Fool Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout November 30, 2022 Via Benzinga Bear Market Blues? 3 of the Best Stocks to Own in 2023 November 19, 2022 2023 could be a big year for each of these healthcare companies. Via The Motley Fool Peering Into Abiomed's Recent Short Interest November 17, 2022 Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that... Via Benzinga 2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield November 11, 2022 Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year? Via The Motley Fool Better Buy: Johnson & Johnson vs. Abbott Laboratories November 10, 2022 These two healthcare giants are among the safest stocks investors can buy right now. Via The Motley Fool Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed November 10, 2022 The company is planting seeds for future growth. Via The Motley Fool 2 Healthcare Stocks You Can Buy and Hold for the Next Decade November 08, 2022 These robust businesses will be around well beyond the next 10 years. Via The Motley Fool 3 No-Brainer Stocks to Buy in a Downturn November 08, 2022 These companies thrive when others falter. Via The Motley Fool Johnson & Johnson's Big Purchase, Amazon's New Moves, and More November 05, 2022 Plus, we run through some shortcuts that could help you with your financial planning. Via The Motley Fool Is Johnson & Johnson's Purchase of Abiomed Good for Investors? November 05, 2022 The $16.6 billion acquisition shakes up MedTech. Via The Motley Fool Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review November 04, 2022 A mixed jobs report and heavy earnings swung stocks. Via Investor's Business Daily Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today November 04, 2022 Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of... Via Benzinga 5 Analysts Have This to Say About Abiomed November 02, 2022 Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 November 02, 2022 Upgrades Via Benzinga Is Johnson & Johnson an Underrated Growth Stock? November 02, 2022 Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium. Via The Motley Fool < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.